Mind Medicine MindMed Inc
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
DFTX$35.39+6.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share amounts)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $99,704 | $142,142 |
| Prepaid and other current assets | 4,168 | 3,913 |
| Total current assets | 103,872 | 146,055 |
| Goodwill | 19,918 | 19,918 |
| Intangible assets, net | 527 | 3,689 |
| Other non-current assets | 224 | 331 |
| Total assets | $124,541 | $169,993 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $4,136 | $2,111 |
| Accrued expenses | 11,634 | 5,877 |
| 2022 USD Financing Warrants | 16,476 | 9,904 |
| Total current liabilities | 32,246 | 17,892 |
| Credit facility, long-term | 14,129 | — |
| Other liabilities, long-term | 32 | 1,184 |
| Total liabilities | 46,407 | 19,076 |
| Commitments and contingencies (Note 11) | ||
| Shareholders' Equity: | ||
| Common shares, no par value, unlimited authorized as of December 31, 2023 and 2022; 41,101,303 and 37,979,136 issued and outstanding as of December 31, 2023 and 2022, respectively | — | — |
| Additional paid-in capital | 367,991 | 344,758 |
| Accumulated other comprehensive income | 343 | 627 |
| Accumulated deficit | (290,200) | (194,468) |
| Total shareholders' equity | 78,134 | 150,917 |
| Total liabilities and shareholders' equity | $124,541 | $169,993 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.